[Pharmacologic studies on the problem of the selective vulnerability of the brain].
D000818:Animals; D000963:Antimetabolites / Q000633:toxicity*; D001921:Brain / Q000187:drug effects* / Q000201:enzymology; D002493:Central Nervous System Diseases / Q000209:etiology* / Q000378:metabolism; D004569:Electroencephalography; D006624:Hippocampus / Q000187:drug effects*; D066298:In Vitro Techniques; D009699:N-Glycosyl Hydrolases / Q000378:metabolism; D009249:NADP / Q000378:metabolism*; D009536:Niacinamide / Q000378:metabolism*; D009696:Nucleic Acids / Q000096:biosynthesis; D009711:Nucleotides / Q000096:biosynthesis*; D014176:Protein Biosynthesis; D011725:Pyridines / Q000633:toxicity*; D051381:Rats; D012640:Seizures / Q000209:etiology
D000963:Antimetabolites; D009696:Nucleic Acids; D009711:Nucleotides; D011725:Pyridines; D009536:Niacinamide; D009249:NADP; D009699:N-Glycosyl Hydrolases
Pharmakologische Untersuchungen zum Problem der selektiven Vulnerabilität des Gehirns.